Legal Representation
Attorney
R. Gwen Peterson
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 27, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 27, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 23, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 20, 2007 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 20, 2007 | I | PAPER RECEIVED | Loading... | |
| Aug 23, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 14, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 14, 2007 | I | PAPER RECEIVED | Loading... | |
| Dec 11, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 23, 2006 | I | PAPER RECEIVED | Loading... | |
| Sep 19, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 27, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 10, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 5, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 2, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Apr 12, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 12, 2006 | I | PAPER RECEIVED | Loading... | |
| Oct 11, 2005 | CPRA | F | PRIORITY ACTION MAILED | Loading... |
| Oct 7, 2005 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Oct 7, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 23, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of central nervous system disorders, Parkinson's disease, spinal cord injury, multiple sclerosis, spasticity, levodopa induced dyskinesia, movement disorders, dementia, and neuropathic pains
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005